Vital Connect is a private medical device company specializing in wearable biosensor technology for wireless patient monitoring in both hospital and remote patient populations
Vital Connect offers a differentiated wearable sensor technology that allows for continuous, real-time cardiac arrhythmia detection while simultaneously measuring patient physiological parameters. The Company’s platform offers physicians a single multi-modal device, multi-parameter monitoring, and real-time 24/7 access to data. Vital Connect leverages its extensive expertise in biomedical engineering, data analytics, chip design, and mobile and cloud software to create technology that supports decision-making paradigms to achieve better clinical and economic outcomes.
Vital Connect products are designed for use in a broad range of inpatient and outpatient settings, including hospital monitoring, post-discharge care, cardiac monitoring and pharmaceutical solutions. In December 2021, EW was the lead investor in a ~$40 million growth equity financing round in Vital Connect to support the Company’s growing commercial efforts and further product development.